Evidence map›Paper›PMID 34695290›Full record

ArticleOral diseases2022

Validity and reliability of immunochromatographic IgM/IgG rapid tests for COVID-19 salivary diagnosis.

Ana Carolina Serafim Vilela, Camila Alves Costa, Suzane Aparecida Oliveira, Menira Borges Lima Dias Souza, Fabiola Souza Fiaccadori, Cláudio Rodrigues Leles, Nádia Lago Costa

Open access · bronzeAbstract read
In one paragraph

Article in Oral diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ana Carolina Serafim VilelaLaboratory of Immunohistochemistry and Saliva Analysis, School of Dentistry, Federal University of Goias, Goiania, Brazil.ORCID https://orcid.org/0000-0002-8123-3361
Camila Alves CostaLaboratory of Immunohistochemistry and Saliva Analysis, School of Dentistry, Federal University of Goias, Goiania, Brazil.ORCID https://orcid.org/0000-0002-8493-1835
Suzane Aparecida OliveiraLaboratory of Immunohistochemistry and Saliva Analysis, School of Dentistry, Federal University of Goias, Goiania, Brazil.ORCID https://orcid.org/0000-0002-6109-2493
Menira Borges Lima Dias SouzaLaboratory of Virology and Cell Culture, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, Brazil.ORCID https://orcid.org/0000-0003-3145-1376
Fabiola Souza FiaccadoriLaboratory of Virology and Cell Culture, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, Brazil.ORCID https://orcid.org/0000-0002-4100-8872
Cláudio Rodrigues LelesDepartment of Oral Rehabilitation, School of Dentistry, Federal University of Goias, Goiania, Brazil.ORCID https://orcid.org/0000-0002-6812-4849
Nádia Lago CostaLaboratory of Immunohistochemistry and Saliva Analysis, School of Dentistry, Federal University of Goias, Goiania, Brazil.ORCID https://orcid.org/0000-0003-0198-5828
Universidade Federal de Goiás · BR

Funding

Fundação de Amparo à Pesquisa do Estado de Goiás CVD2020051000009
6 · The paper itself

Abstract

objectivesTo assess the accuracy of three immunochromatographic rapid tests for salivary detection of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens and the reliability of these tests comparing saliva with plasma samples. MATERIALS AND

methodsPlasma and saliva samples from 62 patients diagnosed with coronavirus disease 2019 (COVID-19) and 20 healthy volunteers were assayed. IgM/IgG antibody against SARS-COV-2 was detected using three immunochromatographic rapid tests and compared with real-time reverse transcription-polymerase chain reaction (qRT-PCR).

resultsThe tests' overall accuracy for detecting anti-SARS-CoV-2 antibodies ranged from 75.6 to 79.3 for saliva and 86.6-87.8 for plasma tests. The sensitivity of saliva and plasma tests increased with the severity of COVID-19 signs and symptoms. The chance of a positive plasma test in participants with a positive qRT-PCR test was 2.27 greater than a positive saliva test.

conclusionsAlthough rapid immunochromatographic tests are more accurate using plasma than saliva, which was expected considering its original use, our findings support the use of saliva as a straightforward supplementary method to assess seroconversion in patients with COVID-19, with important sensitivity and sensibility, especially in severe and critical cases.

Indexed as

COVID-19HumansImmunoglobulin GImmunoglobulin MReproducibility of ResultsSARS-CoV-2Sensitivity and SpecificityImmunoglobulin GImmunoglobulin MCOVID-19immunoglobulin Gimmunoglobulin MsalivaSARS-Cov-2

Identifiers

PMID34695290
PMCPMC8661849
OpenAlexW3210299227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.